Nebulizer Market to Reach $2.3 Billion by 2032, exhibiting a CAGR of 7.8% from 2023 to 2032: Allied Market Research

Rise in prevalence of chronic respiratory diseases such as chronic obstructive pulmonary disorder, asthma and others, cystic fibrosis high presence of market players who manufacture nebulizers and rise in adoption of nebulization treatment at homecare setting is anticipated to drive the…